Mary Gibson

6 papers receiving 534 citations

Hit Papers

Methylprednisolone Infusion in Early Severe ARDS20072026201320192007100200300400500

Peers

Mary Gibson
Comparison fields: 5 of 68
  • Pulmonary and Respiratory Medicine 344
  • Epidemiology 237
  • Critical Care and Intensive Care Medicine 197
  • Emergency Medicine 83
  • Endocrinology, Diabetes and Metabolism 76
Replace Karim Chadda with:
Karim Chadda France
Bernard Bouckaert Belgium
Ilias Andrianakis Greece
Diego Parra Spain
María D. Rincón-Ferrari Spain
Jules Audard France
Marlene Fischer Germany
Michael Schroth Germany
Jean François Benoist France
Mickaël Bobot France
Mary Gibson relative to Karim Chadda France Karim Chadda's profile →
Citations per field
00.5×8.3×
Karim Chadda · 1×
Citations per year

Countries citing papers authored by Mary Gibson

Since Specialization
Citations

This map shows the geographic impact of Mary Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Gibson more than expected).

Fields of papers citing papers by Mary Gibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Gibson. The network helps show where Mary Gibson may publish in the future.

Co-authorship network of co-authors of Mary Gibson

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Gibson. A scholar is included among the top collaborators of Mary Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Gibson. Mary Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 13
2 11
3
Factors associated with anti-TNF treatment in a longitudinally followed ankylosing spondylitis (AS) cohort
0
4
Methylprednisolone Infusion in Early Severe ARDSbreakdown →
503
5 1
6 4
7 17

About Mary Gibson

Mary Gibson is a scholar working on Critical Care and Intensive Care Medicine, Rheumatology and Neurology, having authored 7 papers that have together received 549 indexed citations. Recurring topics across this work include Respiratory Support and Mechanisms (3 papers), Nosocomial Infections in ICU (2 papers) and Intensive Care Unit Cognitive Disorders (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (197 citations), Pulmonary and Respiratory Medicine (344 citations) and Emergency Medicine (83 citations). Mary Gibson has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include G. Umberto Meduri, Reba Umberger, Edwin W. Taylor, Stephanie J. Carson, Emmel Golden, Amado X. Freire, Muhammad Zaman, D J Dick, Judy M. Simpson and Timothy J. Walls. Their work appears in journals such as CHEST Journal, Critical Care Medicine and Muscle & Nerve.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026